Glutathione
US$ 27.79
bpc-157 dosage protocol Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or MOTS-C Dosage Chart: Protocol Guide
Description
Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act
Common Uses: GHK-Cu Tightens loose skin and reverses the thinning of aged skin
Higher Potency Ensures a therapeutic dose, unlike oral supplements that lose potency in digestion
BPC-157 appears to work within normal physiological parameters rather than overriding cellular growth controls
